These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10425314)

  • 21. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
    Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum soluble CD44 level in sarcoidosis.
    Kasuga I; Minemura K; Nasu H; Hibi N; Tago H; Nagate A; Kunisawa A; Ohyashiki JH; Ohyashiki K
    Int J Mol Med; 2000 Dec; 6(6):679-82. PubMed ID: 11078828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer.
    Masson D; Denis MG; Denis M; Blanchard D; Loirat MJ; Cassagnau E; Lustenberger P
    Br J Cancer; 1999 Aug; 80(12):1995-2000. PubMed ID: 10471052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of the serum IL-2R level and Ga-67 scan findings in making a differential diagnosis between sarcoidosis and non-Hodgkin's lymphoma.
    Kita T; Watanabe S; Yano F; Hayashi K; Yamamoto M; Iwasaki Y; Kosuda S
    Ann Nucl Med; 2007 Nov; 21(9):499-503. PubMed ID: 18030581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cells.
    Zeller W; Kröger N; Berger J; Krueger W; Dierlamm J; Stockschläder M; Gutensohn K; Hossfeld DK; Zander AR
    J Hematother Stem Cell Res; 1999 Oct; 8(5):539-46. PubMed ID: 10791904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes.
    Nasu H; Hibi N; Ohyashiki JH; Hara A; Kubono K; Tsukada Y; Ando K; Iwama H; Hayashi S; Yahata N; Toyama K; Ohyashiki K
    Int J Oncol; 1998 Sep; 13(3):525-30. PubMed ID: 9683788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of soluble CD44 and its expression by mononuclear cells in children with acute lymphoblastic leukemia: its relation to prognostic factors.
    Ahmed MI; Hassab HM
    Egypt J Immunol; 2008; 15(2):101-11. PubMed ID: 20306693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
    Sliutz G; Tempfer C; Winkler S; Kohlberger P; Reinthaller A; Kainz C
    Br J Cancer; 1995 Dec; 72(6):1494-7. PubMed ID: 8519665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients.
    Stickeler E; Vogl FD; Denkinger T; Mobus VJ; Kreienberg R; Runnebaum IB
    Int J Mol Med; 2000 Nov; 6(5):595-601. PubMed ID: 11029531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteinase-mediated release of epithelial cell-associated CD44. Extracellular CD44 complexes with components of cellular matrices.
    Cichy J; Bals R; Potempa J; Mani A; Puré E
    J Biol Chem; 2002 Nov; 277(46):44440-7. PubMed ID: 12226094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma.
    Zacharos ID; Efstathiou SP; Petreli E; Georgiou G; Tsioulos DI; Mastorantonakis SE; Christakopoulou I; Roussou PP
    Eur J Haematol; 2002 Oct; 69(4):221-6. PubMed ID: 12431241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intercellular adhesion molecule-1(ICAM-1), CD44s expression and serum level of sICAM-1 in disseminated non-Hodgkin's lymphoma: correlation with overall survival.
    Aboul-Enein M; El-Sayed GM; El-Maghraby S; Abd-Elatif NA; Abd Elwahab GA; Elbasmy AA
    J Egypt Natl Canc Inst; 2004 Dec; 16(4):244-51. PubMed ID: 16116502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum osteopontin and CD44 levels in lymphoreticular malignancies in children.
    Elli M; Dagdemir A; Bozkurt C; Pinarli FG; Duzgun A; Ozmen ZC; Ertem U; Acar S
    Bratisl Lek Listy; 2012; 113(9):534-8. PubMed ID: 22979908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia.
    De Rossi G; Marroni P; Paganuzzi M; Mauro FR; Tenca C; Zarcone D; Velardi A; Molica S; Grossi CE
    Leukemia; 1997 Jan; 11(1):134-41. PubMed ID: 9001429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble CD44 variants in the serum of patients with urological malignancies.
    Lein M; Jung K; Weiss S; Schnorr D; Loening SA
    Oncology; 1997; 54(3):226-30. PubMed ID: 9143404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of HER-2/neu overexpression in non-Hodgkin's lymphoma.
    Lüftner D; Genvresse I; Geppert R; Kaufmann O; Dietel M; Possinger K
    Anticancer Res; 2004; 24(5B):3233-7. PubMed ID: 15510616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.